Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Toscano

Showing results (191-200 of 223) with videos related to

Pageof 23
Sort By:
Journal of Neurology|August 16, 2025
Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trialPriya S Kishnani, Jordi Díaz-Manera, Sergey Illarioshkin, et al.
Orphanet Journal of Rare Diseases|July 24, 2023
Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participationWalaa Karazi, Renata S Scalco, Mads G Stemmerik, et al.
Neuromuscular Disorders : NMD|June 9, 2018
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe diseaseMarco Savarese, Annalaura Torella, Olimpia Musumeci, et al.
Neurology|May 3, 2013
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutationMichelangelo Mancuso, Daniele Orsucci, Corrado Angelini, et al.
Journal of Neurology|December 31, 2013
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?Michelangelo Mancuso, Daniele Orsucci, Corrado Angelini, et al.
European Journal of Neurology|June 14, 2024
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024Benedikt Schoser, Nadine A M E van der Beek, Alexander Broomfield, et al.
Advances in Therapy|March 18, 2019
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study GroupMassimiliano Filosto, Stefano Cotti Piccinelli, Sabrina Ravaglia, et al.
Current Issues in Molecular Biology|May 15, 2023
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD)Paola De Filippi, Edoardo Errichiello, Antonio Toscano, et al.
Muscle & Nerve|May 18, 2016
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosisFrancesca Magri, Vincenzo Nigro, Corrado Angelini, et al.
Stroke (Hoboken, N.J.)|March 12, 2026
Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke: Rationale and Study Protocol of a Multicenter, Randomized, Proof-of-Concept, Phase 2a/b Trial in Patients Treated With Mechanical Thrombectomy (DOWN-SUITE)Francesco Andrea Pedrazzini, Lorenzo Piergallini, Susanna Diamanti, et al.
Pageof 23

Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Journal of Neurology|August 16, 2025
Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trialPriya S Kishnani, Jordi Díaz-Manera, Sergey Illarioshkin, et al.
Orphanet Journal of Rare Diseases|July 24, 2023
Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participationWalaa Karazi, Renata S Scalco, Mads G Stemmerik, et al.
Neuromuscular Disorders : NMD|June 9, 2018
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe diseaseMarco Savarese, Annalaura Torella, Olimpia Musumeci, et al.
Neurology|May 3, 2013
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutationMichelangelo Mancuso, Daniele Orsucci, Corrado Angelini, et al.
Journal of Neurology|December 31, 2013
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?Michelangelo Mancuso, Daniele Orsucci, Corrado Angelini, et al.
European Journal of Neurology|June 14, 2024
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024Benedikt Schoser, Nadine A M E van der Beek, Alexander Broomfield, et al.
Advances in Therapy|March 18, 2019
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study GroupMassimiliano Filosto, Stefano Cotti Piccinelli, Sabrina Ravaglia, et al.
Current Issues in Molecular Biology|May 15, 2023
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD)Paola De Filippi, Edoardo Errichiello, Antonio Toscano, et al.
Muscle & Nerve|May 18, 2016
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosisFrancesca Magri, Vincenzo Nigro, Corrado Angelini, et al.
Stroke (Hoboken, N.J.)|March 12, 2026
Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke: Rationale and Study Protocol of a Multicenter, Randomized, Proof-of-Concept, Phase 2a/b Trial in Patients Treated With Mechanical Thrombectomy (DOWN-SUITE)Francesco Andrea Pedrazzini, Lorenzo Piergallini, Susanna Diamanti, et al.
Pageof 23